As an intellectual property attorney in San Diego, California, I help investors, individual entrepreneurs, innovative companies, universities, and private research institutes bring early-stage and mid-stage technologies to market. In particular, I help clients of all sizes with developing comprehensive intellectual property, regulatory, and business strategies to:
I've spent more than 20 years helping innovators patent their inventions, draft and negotiate business transactions, obtain private and government funding, ensure regulatory compliance, and litigate disputes in state and federal courts. I also help clients connect with investors to fund research and development, clinical trials, patent litigation, and assist with asset/technology purchases, mergers, and acquisitions.
I've also been lucky to work with some of the smartest scientists, researchers, and entrepreneurs in the world. What I enjoy most about working closely with them is sharing the satisfaction of bringing their technologies to market -- whether it be a new therapeutic drug, a new health service, new medical device, or things at the convergence of many disciplines that have never been imagined before. That feeling is just pure magic to me.
Since becoming a lawyer, I have assisted clients with private investments totaling nearly $100 million, and have assisted with the closing of business transactions totaling more than $1 billion. Before returning to San Diego, I worked in a prominent international law firm headquartered in Washington, DC, and after that was the chief legal officer at a large university research foundation. I have also been chief IP counsel in-house with a medical device startup and an international biopharmaceutical company.
Perhaps the impulse to help entrepreneurs with bringing new technologies to market grew out of my desire to always push my own boundaries. I grew up a typical San Diego grom spending as much time in the ocean as I did sleeping. And because I have always loved the sciences, I attended my first biology class at the Scripps Institution of Oceanography when I was 13. That subject spoke to me in a way that nothing else had. When I wasn't in the ocean, rock climbing in Joshua Tree, hiking the High Sierra, and traveling throughout the Southwest and Mexico, you could find me in the lab at UCSD researching the intersection of immunology and cancer.
Before becoming a lawyer, I was a biochemist in both academics and industry. I was fortunate to be raised just down the street from the University of California, San Diego where I was an undergraduate Research Scholar and received a B.S. in Biochemistry/Chemistry with a minor degree in Economics. While conducting research in the laboratory of Dr. Dennis Carson, head of the UC San Diego Moores Cancer Center, I investigated the role of novel purine nucleoside analogs in autoimmune diseases and cytokine mediated cell responses including apoptosis, rheumatoid arthritis, AIDS, and cancers. I then pursued my interests in the biotech industry where I investigated ribonucleic acid (RNA)-based therapeutics for treating viral infections.
I've worked with so many life sciences innovations, but to provide a short list, I have assisted innovators with small molecule pharmaceuticals, biopharmaceuticals, biological drugs and therapeutics, medical devices, convergence technologies including machine learning, artificial intelligence (AI), and complex algorithms, in vitro diagnostics (IVD), companion diagnostics, personalized medicine, pharmacogenomics, stem cells including induced pluripotent stem cells (iPS cells), therapeutic cloning, RNA interference (RNAi), siRNA, shRNA, miRNA, vaccines, monoclonal antibodies, antibody fragments, ribozymes, antisense polynucleotides, enzymes, catalysts, non-naturally occurring polynucleotides and polypeptides, detection and screening assays, bioinformatics, structural proteomics, three-dimensional molecular modeling and drug design, transgenic plants, transgenic animals, and microorganism cell culture.
I founded Torrey Pines Law Group, PC to continue my pursuit of helping truly talented innovators with bringing their technologies to market. I focus on commercializing early-stage and mid-stage technologies within startups, universities, and private research institutes, as well as entrepreneurial divisions of large corporations.